115 related articles for article (PubMed ID: 2055655)
1. MICs of ciprofloxacin and trimethoprim for Escherichia coli: influence of pH, inoculum size and various body fluids.
Aagaard J; Gasser T; Rhodes P; Madsen PO
Infection; 1991; 19 Suppl 3():S167-9. PubMed ID: 2055655
[TBL] [Abstract][Full Text] [Related]
2. Chronic bacterial prostatitis: therapeutic experience with ciprofloxacin.
Weidner W; Schiefer HG
Infection; 1991; 19 Suppl 3():S165-6. PubMed ID: 2055654
[TBL] [Abstract][Full Text] [Related]
3. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.
Vellinga A; Tansey S; Hanahoe B; Bennett K; Murphy AW; Cormican M
J Antimicrob Chemother; 2012 Oct; 67(10):2523-30. PubMed ID: 22729920
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model.
Lee YS; Han CH; Kang SH; Lee SJ; Kim SW; Shin OR; Sim YC; Lee SJ; Cho YH
Int J Urol; 2005 Apr; 12(4):383-9. PubMed ID: 15948727
[TBL] [Abstract][Full Text] [Related]
5. Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae.
So W; Crandon JL; Nicolau DP
J Urol; 2015 Aug; 194(2):563-70. PubMed ID: 25637857
[TBL] [Abstract][Full Text] [Related]
6. Influence of human urine on the in vitro activity and postantibiotic effect of ciprofloxacin against Escherichia coli.
Zhanel GG; Karlowsky JA; Davidson RJ; Hoban DJ
Chemotherapy; 1991; 37(3):218-23. PubMed ID: 1889309
[TBL] [Abstract][Full Text] [Related]
7. Secretion of various antimicrobial substances in dogs with experimental bacterial prostatitis.
Baumueller A; Madsen PO
Urol Res; 1977; 5(4):215-8. PubMed ID: 22949
[TBL] [Abstract][Full Text] [Related]
8. Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli.
Martín-Gutiérrez G; Rodríguez-Beltrán J; Rodríguez-Martínez JM; Costas C; Aznar J; Pascual Á; Blázquez J
Antimicrob Agents Chemother; 2016 Jul; 60(7):4252-8. PubMed ID: 27139482
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and Antimicrobial Effects of Anthocyanin Extracted from Black Soybean on Chronic Bacterial Prostatitis Rat Model.
Yoon BI; Bae WJ; Choi YS; Kim SJ; Ha US; Hong SH; Sohn DW; Kim SW
Chin J Integr Med; 2018 Aug; 24(8):621-626. PubMed ID: 24126975
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory and antimicrobial effects of garlic and synergistic effect between garlic and ciprofloxacin in a chronic bacterial prostatitis rat model.
Sohn DW; Han CH; Jung YS; Kim SI; Kim SW; Cho YH
Int J Antimicrob Agents; 2009 Sep; 34(3):215-9. PubMed ID: 19375896
[TBL] [Abstract][Full Text] [Related]
11. Long-term therapy of chronic bacterial prostatitis with trimethoprim-sulfamethoxazole.
Meares EM
Can Med Assoc J; 1975 Jun; 112(13 Spec No):22-5. PubMed ID: 236820
[TBL] [Abstract][Full Text] [Related]
12. Outcome of antibiotic therapy with ciprofloxacin in chronic bacterial prostatitis.
Weidner W; Ludwig M; Brähler E; Schiefer HG
Drugs; 1999; 58 Suppl 2():103-6. PubMed ID: 10553717
[TBL] [Abstract][Full Text] [Related]
13. Prostatitis. Observations on activity of trimethoprim-sulfamethoxazole in the prostate.
Meares EM
J Infect Dis; 1973 Nov; 128():Suppl:679-85 p. PubMed ID: 4585967
[No Abstract] [Full Text] [Related]
14. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
Jakobsen L; Cattoir V; Jensen KS; Hammerum AM; Nordmann P; Frimodt-Møller N
J Antimicrob Chemother; 2012 Oct; 67(10):2438-44. PubMed ID: 22685162
[TBL] [Abstract][Full Text] [Related]
15. A re-appraisal of treatment in chronic bacterial prostatitis.
Fair WR; Crane DB; Schiller N; Heston WD
J Urol; 1979 Apr; 121(4):437-41. PubMed ID: 35621
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect between lycopene and ciprofloxacin on a chronic bacterial prostatitis rat model.
Han CH; Yang CH; Sohn DW; Kim SW; Kang SH; Cho YH
Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S102-7. PubMed ID: 17920247
[TBL] [Abstract][Full Text] [Related]
17. Trimethoprim sulfamethoxazole therapy of chronic bacterial prostatitis.
Drach GW
J Urol; 1974 May; 111(5):637-9. PubMed ID: 4274697
[No Abstract] [Full Text] [Related]
18. In-vitro investigation of the antibacterial activity of agents which may be used for the oral treatment of lung infections in CF patients.
Richards RM; Hamilton VE; Thomas MR
J Antimicrob Chemother; 1998 Aug; 42(2):171-8. PubMed ID: 9738834
[TBL] [Abstract][Full Text] [Related]
19. The diagnosis and management of bacterial prostatitis.
Meares EM; Stamey TA
Br J Urol; 1972 Apr; 44(2):175-9. PubMed ID: 4557440
[No Abstract] [Full Text] [Related]
20. Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis.
Horcajada JP; Vila J; Moreno-Martínez A; Ruiz J; Martínez JA; Sánchez M; Soriano E; Mensa J
J Antimicrob Chemother; 2002 Jan; 49(1):55-9. PubMed ID: 11751767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
